Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Tomás R, Guilarte"'
Autor:
Damaris Albores-Garcia, Kirstie H. Stansfield, Jennifer L. McGlothan, Zoran Bursac, Tomás R. Guilarte
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 15 (2022)
Exposure to heavy metals has been associated with psychiatric disorders and recent studies suggest an association between childhood lead (Pb2+) intoxication and schizophrenia (SZ). In animal models, Pb2+ exposure recapitulates key neuropathological a
Externí odkaz:
https://doaj.org/article/03ecfd937e4049999431881f3b89724c
Publikováno v:
Neurobiology of Disease, Vol 158, Iss , Pp 105467- (2021)
Inherited autosomal recessive mutations of the manganese (Mn) transporter gene SLC39A14 in humans, results in elevated blood and brain Mn concentrations and childhood-onset dystonia-parkinsonism. The pathophysiology of this disease is unknown, but th
Externí odkaz:
https://doaj.org/article/0b0de1b4d04546769653576d6487760d
Autor:
Meredith K. Loth, Judy Choi, Jennifer L. McGlothan, Mikhail V. Pletnikov, Martin G. Pomper, Tomás R. Guilarte
Publikováno v:
Neurobiology of Disease, Vol 85, Iss , Pp 174-186 (2016)
Translocator protein (18 kDa), formerly known as the peripheral benzodiazepine receptor (PBR), has been extensively used as a biomarker of active brain disease and neuroinflammation. TSPO expression increases dramatically in glial cells, particularly
Externí odkaz:
https://doaj.org/article/05e678f30fbb460bb843d4d751a21128
Publikováno v:
International journal of molecular sciences. 23(21)
Over the last decade, several clinical reports have outlined cases of childhood-onset manganese (Mn)-induced dystonia-parkinsonism, resulting from loss-of-function mutations in the Mn influx transporter gene
Publikováno v:
Curr Opin Toxicol
Lead (Pb(2+)) exposure is a global public health problem of major proportion with an alarming number of children with blood Pb(2+) levels > 10 >g/dL, twice the current CDC reference level for Pb(2+) exposure. Mounting evidence from population-based s
Publikováno v:
Neurotoxicology. 93
Over the last decade, several clinical reports have outlined cases of early-onset manganese (Mn)-induced dystonia-parkinsonism, resulting from loss of function mutations of the Mn transporter gene SLC39A14. Previously, we have performed characterizat
Autor:
Arlet Maria Acanda de la Rocha, Maggie Fader, Ebony R. Coats, Joseph Dunn, Leat Perez, Carolina Velasquez, Jeanette Galano, Cima Saghira, Ileana Sotto, Yana Vorontsova, Ziad Khatib, Haneen Abdella, Cristina M. Andrade-Feraud, Alexa Jacome, Victoria Reis, Lilliam Rimblas, Nicole Tomas, Paula S. Espinal, Noah Berlow, Tomás R. Guilarte, Jennifer McCafferty-Fernandez, Daria Salyakina, Diana J. Azzam
Publikováno v:
Cancer Research. 83:LB358-LB358
Personalized medicine often serves as the first salvage therapy strategy when standard oncology treatments fail. However, most precision oncology approaches rely on molecular profiling which, unfortunately, provides therapeutic options for less than
Autor:
Maximilian Schlecht, Tomás R. Guilarte, Maanasa Jayachandran, Nathan W. Schultheiss, Timothy A. Allen, Deborah R. Brooks, Jennifer L. McGlothan
Publikováno v:
Behav Neurosci
Delta-frequency network activity is commonly associated with sleep or behavioral disengagement accompanied by a dearth of cortical spiking, but delta in awake behaving animals is not well understood. We show that hippocampal (HC) synchronization in t
Publikováno v:
Journal of Leukocyte Biology. 110:123-140
Translocator protein 18 kDa (TSPO) is a well-known outer mitochondrial membrane protein and it is widely used as a biomarker of neuroinflammation and brain injury. Although it is thought that TSPO plays key roles in a multitude of host cell functions
Autor:
Deborah A. Cory-Slechta, Anika L. Dzierlenga, Jonathan A. Hollander, Edward D. Levin, Steven T. Szabo, Mady Hornig, Staci D. Bilbo, Julia L. Zehr, Cindy P. Lawler, Felice N. Jacka, Sheryl S. Moy, Ebrahim Haroon, Kimberly A. McAllister, Christine Ladd-Acosta, Mikhail V. Pletnikov, Amanda E. Garton, Tomás R. Guilarte, Carolyn J. Mattingly
Publikováno v:
Neuropsychopharmacology
The etiologic pathways leading to neuropsychiatric diseases remain poorly defined. As genomic technologies have advanced over the past several decades, considerable progress has been made linking neuropsychiatric disorders to genetic underpinnings. I